Nasal Polyps Clinical Trials

Aggravated Airway Inflammation: Research on Genomics and Optimal Medical Care (AirGOs-medical)

Condition:   Chronic Rhinosinusitis (Diagnosis)
Interventions:   Drug: Placebo Oral Tablet;   Drug: Acetyl Salicylic Acid
Sponsors:   Sanna Salmi;   Helsinki University

Learn More

OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps

Condition:   Bilateral Nasal Polyposis
Intervention:   Drug: OPN-375
Sponsor:   Optinose US Inc.

Learn More

Etokimab in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

Condition:   Chronic Rhinosinusitis
Interventions:   Biological: Etokimab;   Biological: Placebo
Sponsor:   AnaptysBio, Inc.

Learn More

Identifying Serum Cytokine Profiles of Distinct Inflammatory Phenotypes in Severe Asthma

Conditions:   Asthma Persistent;   Asthma, Allergic;   Eosinophilic Asthma;   Chronic Rhinosinusitis (Diagnosis)
Sponsor:   TC Erciyes University
Active, not recruiting

Learn More

An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps

Conditions:   Nasal Polyps;   Chronic Rhinosinusitis
Interventions:   Drug: Omalizumab;   Drug: Placebo
Sponsor:   Hoffmann-La Roche

Learn More

Efficacy and Safety Study of Benralizumab for Patients With Severe Nasal Polyposis

Condition:   Nasal Polyposis
Interventions:   Biological: Benralizumab 30 mg SC + Mometasone Furoate;   Biological: Matching placebo SC + Mometasone Furoate
Sponsor:   AstraZeneca

Learn More

Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis

Conditions:   Healthy;   Chronic Rhinosinusitis With Nasal Polyps;   Atopic Dermatitis
Interventions:   Biological: PF-06817024;   Other: Placebo for PF-06817024
Sponsor:   Pfizer
Active, not recruiting

Learn More

1-7 of 7
Results per page

Join the community!

You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.